We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Introduces XL Range of Fully Automated Clinical Chemistry Systems at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023
Print article
Image: Erba is attending Medlab Middle East 2023 (Photo courtesy of Erba Mannheim)
Image: Erba is attending Medlab Middle East 2023 (Photo courtesy of Erba Mannheim)

Erba Mannheim (London, UK) is introducing its latest XL range of fully automated clinical chemistry systems at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

At Medlab Middle East 2023, Erba is showcasing the XL range of four fully automated clinical chemistry systems that incorporate state-of-the-art features. These rugged and performance-oriented systems boost lab productivity and throughput, making them an essential part of any start-up, medium or advanced lab. They support a wide test menu spanning routine clinical chemistry, electrolytes, immunoassays and coagulation tests. The XL range includes the XL 1000 fully automated clinical chemistry analyzer that guarantees high resolution measurement with automatic sample conveyor for comfortable workflow in laboratories with high sample throughput. It also includes the XL 200 fully automated random access clinical chemistry analyzer having a throughput of 200 tests/hr (photometric test) and 400 tests/hr with ISE (Na/K/Cl/Li). Also part of the XL range is the XL 640 fully automated biochemistry analyzer with a throughput of 640 tests per hour that is powerful and robust enough to keep up with the heavy demands of everyday testing, as well as the XL 180 that is designed to give convenience and flexibility in operation and good quality reporting for small and medium-sized laboratories.

From its hematology line, Erba is highlighting the H360 automated 3-part differential hematology analyzer that can be used as a complete blood count analyzer by small laboratories or as a second instrument. Within its coagulation line, Erba is showcasing the ECL 105 single channel semi-automated system for small laboratories that performs measurements of all clotting assays as well as DDimer. With a color touch-screen and intuitive user interface, the ECL-105 is simple to use and ensures quality results. Also featuring at the show is the LAURA Smart urine strip reader which is an efficient and compact solution for routine chemical urinalysis. The equipment's semi-automatic technology facilitates the sample process, contributing to the correct diagnosis of patients. In addition, Erba is presenting the EC90 electrolyte analyzer featuring clean biosensor and maintenance-free technology. Designed for easy use, efficient operation and reliability, the EC90 has an analysis time of only 35 seconds.

Related Links:
Erba Mannheim 

New
Gold Supplier
D-Dimer Rapid Test
72091
New
Syphilis Ab Assay
EIAgen Syphilis Ab Kit
New
Laboratory Balance
Equinox Precision
New
PCR Automatic Hybridization System
HybriSpot 12 Auto

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: The new assay enables accurate prognosis and detection data for those prone to esophageal cancer (Photo courtesy of Previse)

First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer

Esophageal cancer is among the most lethal cancers in the world and has a 20% five-year survival rate post-diagnosis. Barrett's esophagus is the sole precursor known and is a significant risk factor for... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more

Pathology

view channel
Image: Artificial intelligence predicts genetics of cancerous brain tumors in under 90 seconds (Photo courtesy of Michigan Medicine)

AI-Based Diagnostic Screening System Predicts Genetics of Cancerous Brain Tumors in 90 Seconds

The diagnosis and treatment of gliomas increasingly rely on molecular classification, as surgical benefits and risks vary depending on a patient's genetic makeup. Complete removal of the tumor can extend... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel (Photo courtesy of Roche)

Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's

Presently, obstacles to timely and precise diagnosis of Alzheimer's disease exist globally, resulting in as many as 75% of individuals exhibiting symptoms but lacking a formal diagnosis.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.